Biofilm formation |
Long chain ketone CAI-1 (V. harveyi), Pseudomonas quinolone signal (PQS) (P. aeruginosa) [54] |
Enterococcal surface protein (Esp), (Enterococcus faecium) [58], clumping factor adhesins such as ClfA, ClfB (S. aureus) [59] |
Laccase (Cryptococcus neoformans) [31], beta hexosaminidase, chitinase (C. albicans) [60] |
Drug susceptibility |
β-lactamase (P. aeruginosa) [61], L1 metallo-β-lactamase and L2 serine-β-lactamase (Stenotrophomonas maltophilia) [62] |
MsrR conferring methicillin resistance (S. aureus) [31], penicillin binding proteins (S. aureus) [59] |
Putative glycanosyltransferase (Phr1) and putative endo-beta-D-glucosidase (Sun41) (C. albicans) [60] |
Virulence |
Poreforming toxin ClyA (Escherichia coli) [31], cholera toxin (Vibrio cholerae) [54], CFTR inhibitory factor (P. aeruginosa) [63] |
LLO (Listeria monocytogenes) [31], alpha toxin (Hla), cytolysins, leukocidin subunits such as LukS-PV, LukF-PV, LukE, LukD (S. aureus) [59] |
Galactosaminogalactan (GAG) (Aspergillus fumigatus) [46], capsular polysaccharide glucuronoxylomannan (GXM) (C. neoformans) [55] |
Immune modulation |
Alkaline phosphatase, hemolytic phospholipase C (P. aeruginosa) [37], Cytotoxic necrotizing factor 1 toxin (E. coli) [64] |
Protein A (S. aureus) [57], immune evasion factors such as Sbi, phenol-soluble modulins, catalase, SodA (S. aureus) [59] |
Immunogenic GPI-anchored proteins, such as Phr1 (C. albicans) [46], GXM (C. neoformans) [55] |